Event PartnerOD260 Inc is your ideal partner for the pre-clinical development of oncolytic adenovirus vectors. With more than 20 years experience in the field, we will help you with the design and construction of your vector and the generation of validated virus stocks for in vitro and animal studies (up to 10¹⁵ VP). QC tests include confirmation of virus identity (genome sequencing), physical and infectious titer (VP/IU), genetic and thermal stability, and verification of transgene expression.
ABL, Inc. is a global contract development and manufacturing organization empowering our clients to conquer the world’s most challenging diseases. ABL’s GMP facilities in the U.S. and Europe have established a successful track record manufacturing GMP viruses used for gene therapy, oncolytic vector and vaccine products. Our virus production services include process and assay development, GMP manufacture of bulk drug substance, cGMP aseptic fill and finish of drug product, and QC bioanalytical testing.